BioCentury | Jan 5, 1998
Finance

Stuck in very low gear

...offerings - including Centocor Diagnostics and Osiris on the U.S. side, and RTP Pharma and Orapex...
BioCentury | Dec 8, 1997
Finance

Disgruntled

...and closed the week at $3.875. SCLN has a year of cash. . . . Orapex...
...a joint venture that combines the dental product portfolios of Sepracor (SEPR) and Theratechnologies (ME:TH). Orapex...
BioCentury | Sep 22, 1997
Finance

Franklin's new biotech play

...Canadian IPO for Orapex , a joint venture that combines the partners' dental product portfolios. Orapex...
BioCentury | Sep 22, 1997
Company News

Sepracor, Theratechnologies deal

...The companies formed Orapex Inc. (Montreal), a joint venture that combines the companies' dental product portfolios and...
Items per page:
1 - 4 of 4
BioCentury | Jan 5, 1998
Finance

Stuck in very low gear

...offerings - including Centocor Diagnostics and Osiris on the U.S. side, and RTP Pharma and Orapex...
BioCentury | Dec 8, 1997
Finance

Disgruntled

...and closed the week at $3.875. SCLN has a year of cash. . . . Orapex...
...a joint venture that combines the dental product portfolios of Sepracor (SEPR) and Theratechnologies (ME:TH). Orapex...
BioCentury | Sep 22, 1997
Finance

Franklin's new biotech play

...Canadian IPO for Orapex , a joint venture that combines the partners' dental product portfolios. Orapex...
BioCentury | Sep 22, 1997
Company News

Sepracor, Theratechnologies deal

...The companies formed Orapex Inc. (Montreal), a joint venture that combines the companies' dental product portfolios and...
Items per page:
1 - 4 of 4